MAZE Maze Therapeutics, Inc.
Healthcare$26.07+0.00%OpenMarket Cap: $1.44B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$61.33
Target (Median)
$57.50
Target Range
$46.00 - $97.00
Upside from current price: 135.3%
Rating Distribution
1 Strong Buy11 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-14 | Truist Securities | maintain | Buy | Buy |
| 2026-03-31 | JP Morgan | maintain | Overweight | Overweight |
| 2026-03-25 | BTIG | maintain | Buy | Buy |
| 2026-03-25 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-16 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-04 | Guggenheim | maintain | Buy | Buy |
| 2026-01-16 | BTIG | maintain | Buy | Buy |
| 2025-12-03 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-07 | Wedbush | maintain | Outperform | Outperform |
| 2025-09-29 | JP Morgan | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-3.14 | $1.3M | 8 |
| Fri Dec 31 | $-3.22 | $13.9M | 7 |
| Sun Dec 31 | $-3.63 | $10.7M | 6 |
| Mon Dec 31 | $-3.87 | $51.0M | 4 |